These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2327108)

  • 1. Kinetics of in vitro metabolism of methoxyphenamine in rats.
    Roy SD
    Xenobiotica; 1990 Jan; 20(1):55-70. PubMed ID: 2327108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective in vivo inhibition by quinidine of methoxyphenamine oxidation in rat models of human debrisoquine polymorphism.
    Muralidharan G; Midha KK; McKay G; Hawes EM; Inaba T
    Xenobiotica; 1989 Feb; 19(2):189-97. PubMed ID: 2786289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methoxyphenamine O-demethylase and 5-hydroxylase: a GLC-ECD assay to study their activities and their inhibition by debrisoquine and sparteine.
    Hawes EM; Roy SD; McKay G; Midha KK
    Pharmacol Ther; 1987; 33(1):73-7. PubMed ID: 3628478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinine is a more potent inhibitor than quinidine in rat of the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase.
    Muralidharan G; Hawes EM; McKay G; Midha KK
    Xenobiotica; 1991 Nov; 21(11):1441-50. PubMed ID: 1763518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
    Coutts RT; Bolaji OO; Su P; Baker GB
    Drug Metab Dispos; 1994; 22(5):756-60. PubMed ID: 7835228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of methamphetamine, amphetamine and p-hydroxymethamphetamine by rat-liver microsomal preparations in vitro.
    Yamamoto T; Takano R; Egashira T; Yamanaka Y
    Xenobiotica; 1984 Nov; 14(11):867-75. PubMed ID: 6506759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methoxyphenamine metabolism in rat models of human debrisoquine phenotypes.
    Roy SD; Hawes EM; McKay G; Hubbard JW; Midha KK
    Can J Physiol Pharmacol; 1985 Jul; 63(7):778-81. PubMed ID: 3876145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatography determination of N- and O-demethylase activities of chemicals in human liver microsomes: application of postcolumn fluorescence derivatization using Nash reagent.
    Kobayashi K; Yamamoto T; Taguchi M; Chiba K
    Anal Biochem; 2000 Sep; 284(2):342-7. PubMed ID: 10964418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of etomidate on rabbit liver microsomal drug metabolism in vitro.
    Horai Y; White PF; Trevor AJ
    Drug Metab Dispos; 1985; 13(3):364-7. PubMed ID: 2861997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sparteine and quinidine on the metabolism of methoxyphenamine by Cunninghamella bainieri.
    Foster BC; Wilson DL; McGilveray IJ
    Xenobiotica; 1989 Apr; 19(4):445-52. PubMed ID: 2750204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P4502D and -2C enzymes catalyze the oxidative N-demethylation of the parkinsonism-inducing substance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rat liver microsomes.
    Narimatsu S; Tachibana M; Masubuchi Y; Suzuki T
    Chem Res Toxicol; 1996; 9(1):93-8. PubMed ID: 8924622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple forms of ethoxyresorufin O-de-ethylase and benzphetamine N-demethylase in solubilized and partially resolved rat liver cytochromes P-450.
    Warner M; Neims AH
    Drug Metab Dispos; 1979; 7(3):188-93. PubMed ID: 38092
    [No Abstract]   [Full Text] [Related]  

  • 14. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
    Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of debrisoquin clearance in perfused rat livers and inhibition of dextromethorphan metabolism in human liver microsomes by 4-hydroxydebrisoquin or other metabolites of debrisoquin.
    Jaruratanasirikul S; Cooper AD; Blaschke TF
    Drug Metab Dispos; 1992; 20(3):379-82. PubMed ID: 1355711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of certain vitamin deficiencies on hepatic drug metabolism.
    Zannoni VG; Sato PH
    Fed Proc; 1976 Nov; 35(13):2464-9. PubMed ID: 976490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
    Nebbia C; Ceppa L; Dacasto M; Carletti M; Nachtmann C
    Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine demethylase activity in human and Dark Agouti rat liver microsomes. Comparison with aminopyrine N-demethylase activity.
    Agúndez JA; Luengo A; Benítez J
    Drug Metab Dispos; 1992; 20(3):343-9. PubMed ID: 1521502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.
    Hargreaves MB; Jones BC; Smith DA; Gescher A
    Drug Metab Dispos; 1994; 22(5):806-10. PubMed ID: 7835233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of benzodiazepines on enzyme-metabolizing drugs. III. Activity of microsomal monooxygenases in the rat liver exposed to chlordiazepoxide and elevated environmental temperature].
    Pachecka J; Wegiełek J; Kobylińska K; Bicz W
    Acta Pol Pharm; 1989; 46(2):183-6. PubMed ID: 2561045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.